Despina Contopoulos-Ioannidis, MD

Publications

• Comparative effect sizes in randomised trials from less developed and more developed countries: meta-epidemiological assessment. Panagiotou OA, Contopoulos-Ioannidis DG, Ioannidis JP, Rehnborg CF. BMJ. 2013: 346 f707
• Most meta-analyses of drug interventions have narrow scopes and many focus on specific agents. Haidich AB, Pilalas D, Contopoulos-Ioannidis DG, Ioannidis JP. J Clin Epidemiol. 2013; 66 (4): 371-8
• Patient safety strategies targeted at diagnostic errors: a systematic review. McDonald KM, Matesic B, Contopoulos-Ioannidis DG, Lonhart J, Schmidt E, Pineda N, Ioannidis JP. Ann Intern Med. 2013; 158 (5 Pt 2): 381-9
• Claims for improved survival from systemic corticosteroids in diverse conditions: an umbrella review. Contopoulos-Ioannidis DG, Ioannidis JP. Eur J Clin Invest. 2012; 42 (3): 233-44
• Empirical evaluation of age groups and age-subgroup analyses in pediatric randomized trials and pediatric meta-analyses. Contopoulos-Ioannidis DG, Seto I, Hamm MP, Thomson D, Hartling L, Ioannidis JP, Curtis S, Constantin E, Batmanabane G, Klassen T, Williams K. Pediatrics. 2012: 129 Suppl 3 S161-84
• Standard 6: age groups for pediatric trials. Williams K, Thomson D, Seto I, Contopoulos-Ioannidis DG, Ioannidis JP, Curtis S, Constantin E, Batmanabane G, Hartling L, Klassen T. Pediatrics. 2012: 129 Suppl 3 S153-60
• Different black box warning labeling for same-class drugs. Panagiotou OA, Contopoulos-Ioannidis DG, Papanikolaou PN, Ntzani EE, Ioannidis JP. J Gen Intern Med. 2011; 26 (6): 603-10
• Comparative effectiveness of medical interventions in adults versus children. Contopoulos-Ioannidis DG, Baltogianni MS, Ioannidis JP. J Pediatr. 2010; 157 (2): 322-330.e17
• Reporting and interpretation of SF-36 outcomes in randomised trials: systematic review. Contopoulos-Ioannidis DG, Karvouni A, Kouri I, Ioannidis JP. BMJ. 2009: 338 a3006
• Medicine. Life cycle of translational research for medical interventions. Contopoulos-Ioannidis DG, Alexiou GA, Gouvias TC, Ioannidis JP. Science. 2008; 321 (5894): 1298-9
• Recurrent rhabdomyolysis in a patient with oculocutaneous albinism type 1 and platelet storage-pool deficiency. Contopoulos-Ioannidis D, Evangeliou A, ter Laak H, de Vries B, Pfundt R, Scheffer H, Smeitink J, Tzoufi M, Makis A, Marinos E, Hess R, Adams D, Huizing M, Morava E. Am J Med Genet A. 2008; 146A (23): 3100-3
• Genetic predisposition to asthma and atopy. Contopoulos-Ioannidis DG, Kouri IN, Ioannidis JP. Respiration. 2007; 74 (1): 8-12
• International ranking systems for universities and institutions: a critical appraisal. Ioannidis JP, Patsopoulos NA, Kavvoura FK, Tatsioni A, Evangelou E, Kouri I, Contopoulos-Ioannidis DG, Liberopoulos G. BMC Med. 2007: 5 30
• Pharmacogenetics of the response to beta 2 agonist drugs: a systematic overview of the field. Contopoulos-Ioannidis DG, Kouri I, Ioannidis JP. Pharmacogenomics. 2007; 8 (8): 933-58
• Hereditary hyperferritinemia cataract syndrome in three unrelated families of western Greek origin caused by the C39 > G mutation of L-ferritin IRE. Papanikolaou G, Chandrinou H, Bouzas E, Contopoulos-Ioannidis D, Kalotychou V, Prentzas K, Lilakos K, Asproudis I, Palaiologou D, Premetis E, Papassotiriou I, Sakellaropoulos N. Blood Cells Mol Dis. 2006 Jan-Feb; 36 (1): 33-40
• An empirical evaluation of multifarious outcomes in pharmacogenetics: beta-2 adrenoceptor gene polymorphisms in asthma treatment. Contopoulos-Ioannidis DG, Alexiou GA, Gouvias TC, Ioannidis JP. Pharmacogenet Genomics. 2006; 16 (10): 705-11
• Anticonvulsants for alcohol withdrawal. Polycarpou A, Papanikolaou P, Ioannidis JP, Contopoulos-Ioannidis DG. Cochrane Database Syst Rev. 2005; (3): CD005064
• Comparison of large versus smaller randomized trials for mental health-related interventions. Contopoulos-Ioannidis DG, Gilbody SM, Trikalinos TA, Churchill R, Wahlbeck K, Ioannidis JP. Am J Psychiatry. 2005; 162 (3): 578-84
• Meta-analysis of the association of beta2-adrenergic receptor polymorphisms with asthma phenotypes. Contopoulos-Ioannidis DG, Manoli EN, Ioannidis JP. J Allergy Clin Immunol. 2005; 115 (5): 963-72
• Establishment of genetic associations for complex diseases is independent of early study findings. Trikalinos TA, Ntzani EE, Contopoulos-Ioannidis DG, Ioannidis JP. Eur J Hum Genet. 2004; 12 (9): 762-9
• Extended-interval aminoglycoside administration for children: a meta-analysis. Contopoulos-Ioannidis DG, Giotis ND, Baliatsa DV, Ioannidis JP. Pediatrics. 2004; 114 (1): e111-8
• Treatment options for acute sinusitis in children. Contopoulos-Ioannidis DG, Ioannidis JP. Curr Allergy Asthma Rep. 2004; 4 (6): 471-7
• Acute sinusitis in children: current treatment strategies. Contopoulos-Ioannidis DG, Ioannidis JP, Lau J. Paediatr Drugs. 2003; 5 (2): 71-80
• Effect of CCR5-delta32 heterozygosity on the risk of perinatal HIV-1 infection: a meta-analysis. Contopoulos-Ioannidis DG, O'Brien TR, Goedert JJ, Rosenberg PS, Ioannidis JP. J Acquir Immune Defic Syndr. 2003; 32 (1): 70-6
• Effects of CCR5-delta32 and CCR2-64I alleles on disease progression of perinatally HIV-1-infected children: an international meta-analysis. Ioannidis JP, Contopoulos-Ioannidis DG, Rosenberg PS, Goedert JJ, De Rossi A, Espanol T, Frenkel L, Mayaux MJ, Newell ML, Pahwa SG, Rousseau C, Scarlatti G, Sei S, Sen L, O'Brien TR. AIDS. 2003; 17 (11): 1631-8
• Genetic associations in large versus small studies: an empirical assessment. Ioannidis JP, Trikalinos TA, Ntzani EE, Contopoulos-Ioannidis DG. Lancet. 2003; 361 (9357): 567-71
• Translation of highly promising basic science research into clinical applications. Contopoulos-Ioannidis DG, Ntzani E, Ioannidis JP. Am J Med. 2003; 114 (6): 477-84
• Citation of randomized evidence in support of guidelines of therapeutic and preventive interventions. Giannakakis IA, Haidich AB, Contopoulos-Ioannidis DG, Papanikolaou GN, Baltogianni MS, Ioannidis JP. J Clin Epidemiol. 2002; 55 (6): 545-55
• Comparison of evidence of treatment effects in randomized and nonrandomized studies. Ioannidis JP, Haidich AB, Pappa M, Pantazis N, Kokori SI, Tektonidou MG, Contopoulos-Ioannidis DG, Lau J. JAMA. 2001; 286 (7): 821-30
• Meta-analysis of randomized controlled trials on the comparative efficacy and safety of azithromycin against other antibiotics for lower respiratory tract infections. Contopoulos-Ioannidis DG, Ioannidis JP, Chew P, Lau J. J Antimicrob Chemother. 2001; 48 (5): 691-703
• Meta-analysis of randomized controlled trials on the comparative efficacy and safety of azithromycin against other antibiotics for upper respiratory tract infections. Ioannidis JP, Contopoulos-Ioannidis DG, Chew P, Lau J. J Antimicrob Chemother. 2001; 48 (5): 677-89
• Pathways for inappropriate dispensing of antibiotics for rhinosinusitis: a randomized trial. Contopoulos-Ioannidis DG, Koliofoti ID, Koutroumpa IC, Giannakakis IA, Ioannidis JP. Clin Infect Dis. 2001; 33 (1): 76-82
• Replication validity of genetic association studies. Ioannidis JP, Ntzani EE, Trikalinos TA, Contopoulos-Ioannidis DG. Nat Genet. 2001; 29 (3): 306-9
• Reporting of conflicts of interest in guidelines of preventive and therapeutic interventions. Papanikolaou GN, Baltogianni MS, Contopoulos-Ioannidis DG, Haidich AB, Giannakakis IA, Ioannidis JP. BMC Med Res Methodol. 2001: 1 3
• The carboxyl terminus of the human cytomegalovirus UL37 immediate-early glycoprotein is conserved in primary strains and is important for transactivation. Hayajneh WA, Contopoulos-Ioannidis DG, Lesperance MM, Venegas AM, Colberg-Poley AM. J Gen Virol. 2001; 82 (Pt 7): 1569-79
• The sequence and antiapoptotic functional domains of the human cytomegalovirus UL37 exon 1 immediate early protein are conserved in multiple primary strains. Hayajneh WA, Colberg-Poley AM, Skaletskaya A, Bartle LM, Lesperance MM, Contopoulos-Ioannidis DG, Kedersha NL, Goldmacher VS. Virology. 2001; 279 (1): 233-40
• Maternal viral load and the risk of perinatal transmission of HIV-1. Ioannidis JP, Contopoulos-Ioannidis DG. N Engl J Med. 1999; 341 (22): 1698-700
• Predictors and impact of losses to follow-up in an HIV-1 perinatal transmission cohort in Malawi. Ioannidis JP, Taha TE, Kumwenda N, Broadhead R, Mtimavalye L, Miotti P, Yellin F, Contopoulos-Ioannidis DG, Biggar RJ. Int J Epidemiol. 1999; 28 (4): 769-75
• Recursive cumulative meta-analysis: a diagnostic for the evolution of total randomized evidence from group and individual patient data. Ioannidis JP, Contopoulos-Ioannidis DG, Lau J. J Clin Epidemiol. 1999; 52 (4): 281-91
• Clinical efficacy of high-dose acyclovir in patients with human immunodeficiency virus infection: a meta-analysis of randomized individual patient data. Ioannidis JP, Collier AC, Cooper DA, Corey L, Fiddian AP, Gazzard BG, Griffiths PD, Contopoulos-Ioannidis DG, Lau J, Pavia AT, Saag MS, Spruance SL, Youle MS. J Infect Dis. 1998; 178 (2): 349-59
• Genetic effects on HIV disease progression. Ioannidis JP, O'Brien TR, Rosenberg PS, Contopoulos-Ioannidis DG, Goedert JJ. Nat Med. 1998; 4 (5): 536
• Maternal cell-free viremia in the natural history of perinatal HIV-1 transmission: a meta-analysis. Contopoulos-Ioannidis DG, Ioannidis JP. J Acquir Immune Defic Syndr Hum Retrovirol. 1998; 18 (2): 126-35
• PCR detection of human cytomegalovirus DNA in clinical specimens using novel UL37 exon 3 and US3 primers. Lesperance MM, Contopoulos-Ioannidis DG, del Pilar Gutiérrez M, Colberg-Poley AM. Clin Diagn Lab Immunol. 1998; 5 (2): 256-8
• Reporting of safety data from randomised trials. Ioannidis JP, Contopoulos-Ioannidis DG. Lancet. 1998; 352 (9142): 1752-3